LifeTech Scientific Corporation (HKG:1302)

LifeTech Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	665.76	979.31	833.79	1,119	971.68
Short-Term Investments	205.13	80	-	158.11	170.99
Trading Asset Securities	311	120	-	199	-
Cash & Short-Term Investments	1,182	1,179	833.79	1,476	1,143
Cash Growth	0.22%	41.44%	-43.52%	29.20%	227.39%
Accounts Receivable	136.69	105.19	137.09	110.04	107.14
Other Receivables	478.22	78.62	78.45	51.92	37.59
Receivables	614.91	183.81	215.54	161.96	144.73
Inventory	532.4	483.61	241.41	129.29	99.62
Other Current Assets	4.98	384.42	105.92	69.45	157.82
Total Current Assets	2,334	2,231	1,397	1,837	1,545
Property, Plant & Equipment	976.5	884.86	783.39	724.07	483.52
Long-Term Investments	421.94	531.71	725.5	48.63	421.03
Other Intangible Assets	730.66	75.15	84.42	76.07	35.48
Long-Term Deferred Tax Assets	117.14	83.03	62.6	47	35.9
Long-Term Deferred Charges	-	581.52	357.99	288.76	269.42
Other Long-Term Assets	319.96	308.95	279.56	162.12	164.36
Total Assets	4,900	4,696	3,690	3,184	2,955
Accounts Payable	59.54	124.09	62.65	30.76	18.71
Accrued Expenses	283.67	284.58	290.88	237.14	143.51
Current Portion of Long-Term Debt	-	-	-	-	174.46
Current Portion of Leases	3.79	6.29	5.04	11.05	6.85
Current Income Taxes Payable	32.2	45.94	37.82	34.03	33.03
Current Unearned Revenue	26.09	12.5	13.17	11.43	19.35
Other Current Liabilities	410.34	296.74	175.18	157.51	97.68
Total Current Liabilities	815.64	770.14	584.74	481.91	493.6
Long-Term Leases	1.19	3	4.64	4.63	4.67
Long-Term Unearned Revenue	49.79	40.93	37.17	32.08	30.29
Other Long-Term Liabilities	558.33	558.33	142.5	135	67.5
Total Liabilities	1,425	1,372	769.05	653.61	596.06
Common Stock	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	-	1,643	1,628	1,621	1,608
Retained Earnings	-	1,702	1,439	1,114	821.4
Comprehensive Income & Other	3,494	24.94	-166.88	-231.38	-89.24
Total Common Equity	3,495	3,370	2,900	2,504	2,340
Minority Interest	-19.08	-46.27	20.61	26.52	18.35
Shareholders' Equity	3,475	3,324	2,921	2,530	2,358
Total Liabilities & Equity	4,900	4,696	3,690	3,184	2,955
Total Debt	4.98	9.3	9.67	15.67	185.98
Net Cash (Debt)	1,177	1,170	824.12	1,461	956.69
Net Cash Growth	0.59%	41.97%	-43.58%	52.68%	-
Net Cash Per Share	0.27	0.26	0.19	0.32	0.22
Filing Date Shares Outstanding	4,631	4,630	4,630	4,630	4,627
Total Common Shares Outstanding	4,631	4,630	4,630	4,630	4,627
Working Capital	1,519	1,461	811.92	1,355	1,051
Book Value Per Share	0.75	0.73	0.63	0.54	0.51
Tangible Book Value	2,764	3,295	2,816	2,428	2,305
Tangible Book Value Per Share	0.60	0.71	0.61	0.52	0.50
Buildings	-	641.54	560.72	198.81	198.07
Machinery	-	306.4	262.72	265.59	254.53
Construction In Progress	-	76.04	55.31	325.06	65.83
Leasehold Improvements	-	30.57	28.61	20.44	23.17

Updated Sep 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.